Literature DB >> 932226

Fibrin-fibrinogen degradation products in cerebrospinal fluid.

M J Brueton, G R Breeze, J Stuart.   

Abstract

An increase in low molecular weight fibrin-fibrinogen degradation products (FDP) was demonstrated in cerebrospinal fluid (CSF) from 17 of 18 patients with bacterial or viral meningitis compared with 29 patients without meningitis. The CSF also showed an increase in coagulation proteins of molecular weight less than 90000 (factors VII, IX, and plasminogen) but did not contain fibrinogen (MW 340000) or plasminogen activator. It is concluded that low molecular weight FDP in the CSF in infective meningitis result from leakage through a damaged blood-CSF barrier rather than from local digestion of fibrin deposited on the meninges.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932226      PMCID: PMC476059          DOI: 10.1136/jcp.29.4.341

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

2.  New one-stage procedures for the quantitative determination of prothrombin and labile factor.

Authors:  M STEFANINI
Journal:  Am J Clin Pathol       Date:  1950-03       Impact factor: 2.493

3.  Arteriographic demonstration of vascular lesions in the study of neurologic deficit in advanced Haemophilus influenzae meningitis.

Authors:  V H Thomas; I J Hopkins
Journal:  Dev Med Child Neurol       Date:  1972-12       Impact factor: 5.449

4.  Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.

Authors:  R Hunter; T Thomson; C M Reynolds; P M Pitcher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

5.  Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.

Authors:  D Tovi; I M Nilsson; C A Thulin
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

6.  Angiographic manifestations in cerebral inflammatory disease.

Authors:  N E Leeds; H I Goldberg
Journal:  Radiology       Date:  1971-03       Impact factor: 11.105

7.  Antifibrinolytic therapy for intracranial aneurysms.

Authors:  S Mullan; J Dawley
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

8.  Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms.

Authors:  J R Gibbs; A G Corkill
Journal:  Postgrad Med J       Date:  1971-04       Impact factor: 2.401

9.  Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis.

Authors:  M J Brueton; P Tugwell; H C Whittle; B M Greenwood
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

10.  Detection of fibrinogen antigens with two latex techniques applied to urine concentrates.

Authors:  M B Donati; N Semeraro; J Vermylen
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

View more
  8 in total

Review 1.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review.

Authors:  Yosef Laviv; Burkhard Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-11       Impact factor: 3.042

2.  Childhood bacterial meningitis.

Authors:  R H Lye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

3.  Coagulation and fibrinolytic activity of cerebrospinal fluid.

Authors:  M Anderson; K B Matthews; J Stuart
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

4.  Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis.

Authors:  P G Cleland; J T Macfarlane; D R Baird; B M Greenwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-09       Impact factor: 10.154

5.  Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.

Authors:  Upali R Goonetilleke; Matthew Scarborough; Stephen A Ward; Stephen B Gordon
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

Authors:  H Fodstad; I M Nilsson
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

7.  The nitroblue-tetrazolium test in granulocytes of the cerebrospinal fluid--methodological problems.

Authors:  H W Kölmel; T Egri
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.

Authors:  H Fodstad; A Pilbrant; M Schannong; S Strömberg
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.